Abstract:
Devices and method for warm gas therapy is provided. Device comprises a gas warmer assembly to warm a first gas to a temperature in a first temperature range to obtain warm first gas. The device comprises a first delivery unit that can deliver the warm first gas to a main treatment chamber which encloses a sub-treatment chamber to retain heat therein. A second delivery unit can receive a therapeutic gas from a gas supply. The second delivery unit comprises a first portion and a second portion. The first portion substantially passes through the first delivery unit and therapeutic gas in the first portion is warmed by the warm first gas. The second portion delivers the warm therapeutic gas to a sub-treatment chamber. The sub-treatment chamber encloses a body part of a patient.
Abstract:
Devices and methods for delivering oxygen and other therapeutic gases to a target, such as a tissue, a tissue-engineered construct, and a wound, in a controlled and sustained manner are disclosed.
Abstract:
A therapeutic device for treating one or more conditions associated with a user's nasal cavities, sinuses, and/or ear canals. The therapeutic device includes a vibration generator that includes an acoustic device configured to provide a sound. The therapeutic device further includes a seal that may be applied to a nasal interface of the user, the nasal interface being located around the nose and/or mouth of the user. The therapeutic device further includes a housing that the user may hold and that is connected to the vibration generator and the seal. The sound may be applied to the nasal interface of the user when the seal is applied to the nasal interface of the user.
Abstract:
The present disclosure is generally related to devices, methods and systems for cleaning, disinfecting and/or sterilizing a medical device, medical hoses and tubes and accessories thereof with ozone gas, in particular the disclosure relates to devices, methods and systems with multiple receptacles for providing closed-loop fluid pathways to distribute ozone gas to inner passageways and the outer compartments of medical devices. The devices in accordance with an embodiment of the disclosure have two or more receptacles for distributing ozone gas, a gas-tight compartment, an ozone operating system, and one or more connector units configured to fluidly migrate ozone in closed-loop treatment systems.
Abstract:
Oxygen-charged (or oxygen-rich) implantable medical devices for and methods of local delivery of oxygen via outgassing is disclosed. The presently disclosed oxygen-charged implantable medical devices are, for example, polymeric implants that are functionalized to locally deliver oxygen from the implant surface for prolonged periods of time, thus increasing rates of healing and reducing rates of infection as compared with conventional medical implant devices.
Abstract:
The disclosure is directed in general to a portable device for the non-invasive treatment of headaches and mood disorders. Specifically, the disclosure is directed to a portable device capable of simultaneously and selectively generate at least three synergistic modes of treatment of headaches and mood disorders at varying intensities and durations.
Abstract:
In accordance with at least one exemplary embodiment, a syringe device, method and system for delivering a therapeutic amount of ozone are disclosed. A sterility case can enclose a syringe portion and can maintain sterility while the syringe device is interfaced to an ozone generator. A valvably-controlled fluid channel can extend from the barrel of the syringe through the case. Conducting elements can be attached to the case and can breach the case. The conductive elements can be connected to electrodes. The electrodes can be attached to the syringe. The syringe portion can be filled with oxygen gas via the valvably-controlled fluid channel. An electric current can be provided to the conductive elements from an ozone generator resulting in a corona discharge from at least one electrode. A therapeutic amount of ozone gas can be produced from the oxygen gas and the syringe delivered into the sterile field without compromise.
Abstract:
Methods are provided for treatment of acute ischemic brain stroke based on the delivery of a measured amount of ozone to a sample of a mammalian patient's blood, blood fractionate or other biological fluid through the use of an ozone delivery system. The ozone-treated fluid, having absorbed a quantifiable absorbed-dose of ozone, is subsequently reinfused into the same patient and the autologous blood sample provides therapeutic effects to the patient, such as reduction in edema associated with the ischemic penumbra, improvement in impaired blood flow to the area surrounding the infarct, relaxation of the vascular endothelium and reduction of inflammation.
Abstract:
An apparatus for administering a therapeutic is provided. In various embodiments, the apparatus includes a syringe having a barrel and a plunger and having an ozone generator associated therewith. The generator is initiated and a therapeutic gas is accumulated within the barrel, at which point it can be delivered from the barrel into a target site via a needle, thereby delivering therapeutic effects to that target site.
Abstract:
An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.